Home » Topics » BioWorld Science

BioWorld Science
RSS

National Health Research Institutes reports development of tyrosine kinase inhibitors

Dec. 31, 2018

Tianjin Zhongxin Pharmaceutical Research Center reports agents for treatment of cancer

Dec. 31, 2018

PTC Therapeutics patents compounds for Huntington's disease

Dec. 31, 2018

Bristol-Myers Squibb describes formyl peptide receptor agonists

Dec. 31, 2018

Anti-RSV compounds reported in Enanta Pharmaceuticals patent

Dec. 31, 2018

University of Southern California patent describes agents for imaging ADP-ribosylation

Dec. 31, 2018

InventisBio and Betta Pharma sign Chinese agreement for D-0316

Dec. 31, 2018

Emergent BioSolutions makes FDA submission for potential emergency use of NuThrax

Dec. 31, 2018

Transcription factor suppresses immunity, halts lupus in mice

Dec. 31, 2018

Novel SIRT6 allosteric activator, MDL-800, suppresses tumor growth in xenograft models of HCC

Dec. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...